Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1993 Oct 1;178(4):1175–1188. doi: 10.1084/jem.178.4.1175

Progenitor cell hyperplasia with rare development of myeloid leukemia in interleukin 11 bone marrow chimeras

PMCID: PMC2191207  PMID: 8104229

Abstract

Post 5-fluorouracil-treated murine bone marrow cells infected with a recombinant retrovirus (murine stem cell virus-interleukin 11 [MSCV-IL- 11]) bearing a human IL-11 gene were transplanted into lethally irradiated syngeneic mice. Analysis of proviral integration sites in DNA prepared from hematopoietic tissues and purified cell populations of long-term reconstituted primary and secondary recipients demonstrated polyclonal engraftment by multipotential stem cells. High levels (100-1,500 U/ml) of IL-11 were detected in the plasma of the MSCV-IL-11 mice. Systemic effects of chronic IL-11 exposure included loss of body fat, thymus atrophy, some alterations in plasma protein levels, frequent inflammation of the eyelids, and often a hyperactive state. A sustained rise in peripheral platelet levels (approximately 1.5-fold) was seen throughout the observation period (4-17 wk). No changes were observed in the total number of circulating leukocytes in the majority of the transplanted animals (including 10 primary and 18 secondary recipients) despite a > 20-fold elevation in myeloid progenitor cell content in the spleen. The exceptions were members of one transplant pedigree which presented with myeloid leukemia during the secondary transplant phase. A clonal origin of the disease was determined, with significant expansion of the MSCV-IL-11-marked clone having occurred in the spleen of the primary host. Culturing of leukemic spleen cells from a quaternary recipient led to the establishment of a permanent cell line (denoted PGMD1). IL-11-producing PGMD1 myeloid leukemic cells are dependent on IL-3 for continuous growth in vitro and they differentiate into granulocytes and macrophages in response to granulocyte/macrophage colony-stimulating factor. The inability of autogenously produced IL-11 to support autonomous growth of PGMD1 cells argues against a mechanism of transformation involving a classical autocrine loop.

Full Text

The Full Text of this article is available as a PDF (2.5 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarden L. A., De Groot E. R., Schaap O. L., Lansdorp P. M. Production of hybridoma growth factor by human monocytes. Eur J Immunol. 1987 Oct;17(10):1411–1416. doi: 10.1002/eji.1830171004. [DOI] [PubMed] [Google Scholar]
  2. Anderson K. C., Morimoto C., Paul S. R., Chauhan D., Williams D., Cochran M., Barut B. A. Interleukin-11 promotes accessory cell-dependent B-cell differentiation in humans. Blood. 1992 Dec 1;80(11):2797–2804. [PubMed] [Google Scholar]
  3. Baumann H., Schendel P. Interleukin-11 regulates the hepatic expression of the same plasma protein genes as interleukin-6. J Biol Chem. 1991 Oct 25;266(30):20424–20427. [PubMed] [Google Scholar]
  4. Beck E., Ludwig G., Auerswald E. A., Reiss B., Schaller H. Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5. Gene. 1982 Oct;19(3):327–336. doi: 10.1016/0378-1119(82)90023-3. [DOI] [PubMed] [Google Scholar]
  5. Brandt S. J., Bodine D. M., Dunbar C. E., Nienhuis A. W. Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest. 1990 Aug;86(2):592–599. doi: 10.1172/JCI114749. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bruno E., Briddell R. A., Cooper R. J., Hoffman R. Effects of recombinant interleukin 11 on human megakaryocyte progenitor cells. Exp Hematol. 1991 Jun;19(5):378–381. [PubMed] [Google Scholar]
  7. Burger R., Gramatzki M. Responsiveness of the interleukin (IL)-6-dependent cell line B9 to IL-11. J Immunol Methods. 1993 Jan 14;158(1):147–148. doi: 10.1016/0022-1759(93)90266-a. [DOI] [PubMed] [Google Scholar]
  8. Chodakewitz J. A., Kupper T. S., Coleman D. L. Keratinocyte-derived granulocyte/macrophage colony-stimulating factor induces DNA synthesis by peritoneal macrophages. J Immunol. 1988 Feb 1;140(3):832–836. [PubMed] [Google Scholar]
  9. Du X. X., Neben T., Goldman S., Williams D. A. Effects of recombinant human interleukin-11 on hematopoietic reconstitution in transplant mice: acceleration of recovery of peripheral blood neutrophils and platelets. Blood. 1993 Jan 1;81(1):27–34. [PubMed] [Google Scholar]
  10. Fearon E. R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990 Jun 1;61(5):759–767. doi: 10.1016/0092-8674(90)90186-i. [DOI] [PubMed] [Google Scholar]
  11. Gasparetto C., Laver J., Abboud M., Gillio A., Smith C., O'Reilly R. J., Moore M. A. Effects of interleukin-1 on hematopoietic progenitors: evidence of stimulatory and inhibitory activities in a primate model. Blood. 1989 Aug 1;74(2):547–550. [PubMed] [Google Scholar]
  12. Gauldie J., Richards C., Harnish D., Lansdorp P., Baumann H. Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci U S A. 1987 Oct;84(20):7251–7255. doi: 10.1073/pnas.84.20.7251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gearing D. P., Comeau M. R., Friend D. J., Gimpel S. D., Thut C. J., McGourty J., Brasher K. K., King J. A., Gillis S., Mosley B. The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science. 1992 Mar 13;255(5050):1434–1437. doi: 10.1126/science.1542794. [DOI] [PubMed] [Google Scholar]
  14. Gruss H. J., Brach M. A., Herrmann F. Involvement of nuclear factor-kappa B in induction of the interleukin-6 gene by leukemia inhibitory factor. Blood. 1992 Nov 15;80(10):2563–2570. [PubMed] [Google Scholar]
  15. Hangoc G., Yin T., Cooper S., Schendel P., Yang Y. C., Broxmeyer H. E. In vivo effects of recombinant interleukin-11 on myelopoiesis in mice. Blood. 1993 Feb 15;81(4):965–972. [PubMed] [Google Scholar]
  16. Hapel A. J., Warren H. S., Hume D. A. Different colony-stimulating factors are detected by the "interleukin-3"-dependent cell lines FDC-Pl and 32D cl-23. Blood. 1984 Oct;64(4):786–790. [PubMed] [Google Scholar]
  17. Harris J. F., Hawley R. G., Hawley T. S., Crawford-Sharpe G. C. Increased frequency of both total and specific monoclonal antibody producing hybridomas using a fusion partner that constitutively expresses recombinant IL-6. J Immunol Methods. 1992 Apr 8;148(1-2):199–207. doi: 10.1016/0022-1759(92)90173-q. [DOI] [PubMed] [Google Scholar]
  18. Hawley R. G., Covarrubias L., Hawley T., Mintz B. Handicapped retroviral vectors efficiently transduce foreign genes into hematopoietic stem cells. Proc Natl Acad Sci U S A. 1987 Apr;84(8):2406–2410. doi: 10.1073/pnas.84.8.2406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hawley R. G., Fong A. Z., Burns B. F., Hawley T. S. Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus. J Exp Med. 1992 Oct 1;176(4):1149–1163. doi: 10.1084/jem.176.4.1149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hawley T. S., Burns B. F., Hawley R. G. Leukocytosis in mice following long-term reconstitution with genetically-modified bone marrow cells constitutively expressing interleukin 1 alpha or interleukin 6. Leuk Res. 1991;15(8):659–673. doi: 10.1016/0145-2126(91)90068-5. [DOI] [PubMed] [Google Scholar]
  21. Hawley T. S., Lach B., Burns B. F., May L. T., Sehgal P. B., Hawley R. G. Expression of retrovirally transduced IL-1 alpha in IL-6-dependent B cells: a murine model of aggressive multiple myeloma. Growth Factors. 1991;5(4):327–338. doi: 10.3109/08977199109000296. [DOI] [PubMed] [Google Scholar]
  22. Hawley T. S., McLeish W. A., Hawley R. G. Establishment of a novel factor-dependent myeloid cell line from primary cultures of mouse bone marrow. Cytokine. 1991 Jan;3(1):60–71. doi: 10.1016/1043-4666(91)90011-2. [DOI] [PubMed] [Google Scholar]
  23. Hawley T. S., Sabourin L. A., Hawley R. G. Comparative analysis of retroviral vector expression in mouse embryonal carcinoma cells. Plasmid. 1989 Sep;22(2):120–131. doi: 10.1016/0147-619x(89)90021-8. [DOI] [PubMed] [Google Scholar]
  24. Hu J. P., Cesano A., Santoli D., Clark S. C., Hoang T. Effects of interleukin-11 on the proliferation and cell cycle status of myeloid leukemic cells. Blood. 1993 Mar 15;81(6):1586–1592. [PubMed] [Google Scholar]
  25. Ishibashi T., Kimura H., Shikama Y., Uchida T., Kariyone S., Hirano T., Kishimoto T., Takatsuki F., Akiyama Y. Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood. 1989 Sep;74(4):1241–1244. [PubMed] [Google Scholar]
  26. Kaleko M., Garcia J. V., Osborne W. R., Miller A. D. Expression of human adenosine deaminase in mice after transplantation of genetically-modified bone marrow. Blood. 1990 Apr 15;75(8):1733–1741. [PubMed] [Google Scholar]
  27. Kawashima I., Ohsumi J., Mita-Honjo K., Shimoda-Takano K., Ishikawa H., Sakakibara S., Miyadai K., Takiguchi Y. Molecular cloning of cDNA encoding adipogenesis inhibitory factor and identity with interleukin-11. FEBS Lett. 1991 Jun 3;283(2):199–202. doi: 10.1016/0014-5793(91)80587-s. [DOI] [PubMed] [Google Scholar]
  28. Kobayashi S., Teramura M., Sugawara I., Oshimi K., Mizoguchi H. Interleukin-11 acts as an autocrine growth factor for human megakaryoblastic cell lines. Blood. 1993 Feb 15;81(4):889–893. [PubMed] [Google Scholar]
  29. Lang R. A., Burgess A. W. Autocrine growth factors and tumourigenic transformation. Immunol Today. 1990 Jul;11(7):244–249. doi: 10.1016/0167-5699(90)90098-t. [DOI] [PubMed] [Google Scholar]
  30. Leslie K. B., Ziltener H. J., Schrader J. W. The role of interleukin-1 and granulocyte-macrophage colony-stimulating factor in the paracrine stimulation of an in vivo-derived murine myeloid leukemia. Blood. 1991 Sep 1;78(5):1301–1310. [PubMed] [Google Scholar]
  31. Lord K. A., Abdollahi A., Thomas S. M., DeMarco M., Brugge J. S., Hoffman-Liebermann B., Liebermann D. A. Leukemia inhibitory factor and interleukin-6 trigger the same immediate early response, including tyrosine phosphorylation, upon induction of myeloid leukemia differentiation. Mol Cell Biol. 1991 Sep;11(9):4371–4379. doi: 10.1128/mcb.11.9.4371. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Markowitz D., Goff S., Bank A. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol. 1988 Apr;62(4):1120–1124. doi: 10.1128/jvi.62.4.1120-1124.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Metcalf D., Begley C. G., Johnson G. R., Nicola N. A., Lopez A. F., Williamson D. J. Effects of purified bacterially synthesized murine multi-CSF (IL-3) on hematopoiesis in normal adult mice. Blood. 1986 Jul;68(1):46–57. [PubMed] [Google Scholar]
  34. Metcalf D., Gearing D. P. Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. Proc Natl Acad Sci U S A. 1989 Aug;86(15):5948–5952. doi: 10.1073/pnas.86.15.5948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Metcalf D., Nicola N. A., Gearing D. P. Effects of injected leukemia inhibitory factor on hematopoietic and other tissues in mice. Blood. 1990 Jul 1;76(1):50–56. [PubMed] [Google Scholar]
  36. Morishita K., Parker D. S., Mucenski M. L., Jenkins N. A., Copeland N. G., Ihle J. N. Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines. Cell. 1988 Sep 9;54(6):831–840. doi: 10.1016/s0092-8674(88)91175-0. [DOI] [PubMed] [Google Scholar]
  37. Musashi M., Clark S. C., Sudo T., Urdal D. L., Ogawa M. Synergistic interactions between interleukin-11 and interleukin-4 in support of proliferation of primitive hematopoietic progenitors of mice. Blood. 1991 Sep 15;78(6):1448–1451. [PubMed] [Google Scholar]
  38. Musashi M., Yang Y. C., Paul S. R., Clark S. C., Sudo T., Ogawa M. Direct and synergistic effects of interleukin 11 on murine hemopoiesis in culture. Proc Natl Acad Sci U S A. 1991 Feb 1;88(3):765–769. doi: 10.1073/pnas.88.3.765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Nakahata T., Ogawa M. Clonal origin of murine hemopoietic colonies with apparent restriction to granuclocyte-macrophage-megakaryocyte (GMM) differentiation. J Cell Physiol. 1982 Jun;111(3):239–246. doi: 10.1002/jcp.1041110304. [DOI] [PubMed] [Google Scholar]
  40. Neben T. Y., Loebelenz J., Hayes L., McCarthy K., Stoudemire J., Schaub R., Goldman S. J. Recombinant human interleukin-11 stimulates megakaryocytopoiesis and increases peripheral platelets in normal and splenectomized mice. Blood. 1993 Feb 15;81(4):901–908. [PubMed] [Google Scholar]
  41. Patchen M. L., MacVittie T. J., Williams J. L., Schwartz G. N., Souza L. M. Administration of interleukin-6 stimulates multilineage hematopoiesis and accelerates recovery from radiation-induced hematopoietic depression. Blood. 1991 Feb 1;77(3):472–480. [PubMed] [Google Scholar]
  42. Paul S. R., Barut B. A., Bennett F., Cochran M. A., Anderson K. C. Lack of a role of interleukin 11 in the growth of multiple myeloma. Leuk Res. 1992;16(3):247–252. doi: 10.1016/0145-2126(92)90062-c. [DOI] [PubMed] [Google Scholar]
  43. Paul S. R., Bennett F., Calvetti J. A., Kelleher K., Wood C. R., O'Hara R. M., Jr, Leary A. C., Sibley B., Clark S. C., Williams D. A. Molecular cloning of a cDNA encoding interleukin 11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci U S A. 1990 Oct;87(19):7512–7516. doi: 10.1073/pnas.87.19.7512. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Paul S. R., Yang Y. C., Donahue R. E., Goldring S., Williams D. A. Stromal cell-associated hematopoiesis: immortalization and characterization of a primate bone marrow-derived stromal cell line. Blood. 1991 Apr 15;77(8):1723–1733. [PubMed] [Google Scholar]
  45. Piechaczyk M., Blanchard J. M., Marty L., Dani C., Panabieres F., El Sabouty S., Fort P., Jeanteur P. Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissues. Nucleic Acids Res. 1984 Sep 25;12(18):6951–6963. doi: 10.1093/nar/12.18.6951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Preston-Martin S., Pike M. C., Ross R. K., Jones P. A., Henderson B. E. Increased cell division as a cause of human cancer. Cancer Res. 1990 Dec 1;50(23):7415–7421. [PubMed] [Google Scholar]
  47. Quesniaux V. F., Clark S. C., Turner K., Fagg B. Interleukin-11 stimulates multiple phases of erythropoiesis in vitro. Blood. 1992 Sep 1;80(5):1218–1223. [PubMed] [Google Scholar]
  48. Quesniaux V. F., Mayer P., Liehl E., Turner K., Goldman S. J., Fagg B. Review of a novel hematopoietic cytokine, interleukin-11. Int Rev Exp Pathol. 1993;34(Pt A):205–214. [PubMed] [Google Scholar]
  49. Rich B. E., Campos-Torres J., Tepper R. I., Moreadith R. W., Leder P. Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice. J Exp Med. 1993 Feb 1;177(2):305–316. doi: 10.1084/jem.177.2.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Sabourin L. A., Hawley R. G. Suppression of programmed death and G1 arrest in B-cell hybridomas by interleukin-6 is not accompanied by altered expression of immediate early response genes. J Cell Physiol. 1990 Dec;145(3):564–574. doi: 10.1002/jcp.1041450325. [DOI] [PubMed] [Google Scholar]
  51. Shabo Y., Sachs L. Inhibition of differentiation and affinity purification with a monoclonal antibody to a myeloid cell differentiation-inducing protein. Blood. 1988 Nov;72(5):1543–1549. [PubMed] [Google Scholar]
  52. Suematsu S., Matsuda T., Aozasa K., Akira S., Nakano N., Ohno S., Miyazaki J., Yamamura K., Hirano T., Kishimoto T. IgG1 plasmacytosis in interleukin 6 transgenic mice. Proc Natl Acad Sci U S A. 1989 Oct;86(19):7547–7551. doi: 10.1073/pnas.86.19.7547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Suematsu S., Matsusaka T., Matsuda T., Ohno S., Miyazaki J., Yamamura K., Hirano T., Kishimoto T. Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice. Proc Natl Acad Sci U S A. 1992 Jan 1;89(1):232–235. doi: 10.1073/pnas.89.1.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Taga T., Narazaki M., Yasukawa K., Saito T., Miki D., Hamaguchi M., Davis S., Shoyab M., Yancopoulos G. D., Kishimoto T. Functional inhibition of hematopoietic and neurotrophic cytokines by blocking the interleukin 6 signal transducer gp130. Proc Natl Acad Sci U S A. 1992 Nov 15;89(22):10998–11001. doi: 10.1073/pnas.89.22.10998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Teramura M., Kobayashi S., Hoshino S., Oshimi K., Mizoguchi H. Interleukin-11 enhances human megakaryocytopoiesis in vitro. Blood. 1992 Jan 15;79(2):327–331. [PubMed] [Google Scholar]
  56. Tohyama N., Karasuyama H., Tada T. Growth autonomy and tumorigenicity of interleukin 6-dependent B cells transfected with interleukin 6 cDNA. J Exp Med. 1990 Feb 1;171(2):389–400. doi: 10.1084/jem.171.2.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Tsuji K., Lyman S. D., Sudo T., Clark S. C., Ogawa M. Enhancement of murine hematopoiesis by synergistic interactions between steel factor (ligand for c-kit), interleukin-11, and other early acting factors in culture. Blood. 1992 Jun 1;79(11):2855–2860. [PubMed] [Google Scholar]
  58. Ulich T. R., Guo K. Z., Remick D., del Castillo J., Yin S. M. Endotoxin-induced cytokine gene expression in vivo. III. IL-6 mRNA and serum protein expression and the in vivo hematologic effects of IL-6. J Immunol. 1991 Apr 1;146(7):2316–2323. [PubMed] [Google Scholar]
  59. Ulich T. R., del Castillo J., Guo K. Z. In vivo hematologic effects of recombinant interleukin-6 on hematopoiesis and circulating numbers of RBCs and WBCs. Blood. 1989 Jan;73(1):108–110. [PubMed] [Google Scholar]
  60. Van Snick J., Cayphas S., Szikora J. P., Renauld J. C., Van Roost E., Boon T., Simpson R. J. cDNA cloning of murine interleukin-HP1: homology with human interleukin 6. Eur J Immunol. 1988 Feb;18(2):193–197. doi: 10.1002/eji.1830180202. [DOI] [PubMed] [Google Scholar]
  61. Vink A., Coulie P., Warnier G., Renauld J. C., Stevens M., Donckers D., Van Snick J. Mouse plasmacytoma growth in vivo: enhancement by interleukin 6 (IL-6) and inhibition by antibodies directed against IL-6 or its receptor. J Exp Med. 1990 Sep 1;172(3):997–1000. doi: 10.1084/jem.172.3.997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Yang Y. C., Yin T. Interleukin-11 and its receptor. Biofactors. 1992 Dec;4(1):15–21. [PubMed] [Google Scholar]
  63. Yin T. G., Schendel P., Yang Y. C. Enhancement of in vitro and in vivo antigen-specific antibody responses by interleukin 11. J Exp Med. 1992 Jan 1;175(1):211–216. doi: 10.1084/jem.175.1.211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Yin T., Miyazawa K., Yang Y. C. Characterization of interleukin-11 receptor and protein tyrosine phosphorylation induced by interleukin-11 in mouse 3T3-L1 cells. J Biol Chem. 1992 Apr 25;267(12):8347–8351. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES